Comparison of clinical outcomes of cabozantinib plus nivolumab and lenvatinib plus pembrolizumab in patients with metastatic renal cell carcinoma

Kazutaka Nakamura(Tokyo Women's Medical University Hospital), Toshio Takagi(Tokyo Women's Medical University), Hiroaki Shimmura(Jyoban Hospital of Tokiwa Foundation), Kazuhiko Yoshida(Tokyo Women's Medical University), Hironori Fukuda(Tokyo Women's Medical University), Junpei Iizuka(Tokyo Women's Medical University), Yuki Nemoto(Jyoban Hospital of Tokiwa Foundation), Hiroki Ishihara, Tsunenori Kondo(Tokyo Women's Medical University Adachi Medical Center), Yasunobu Hashimoto, Hiroshi Kobayashi(Saiseikai Ibaraki Hospital), Yuki Kobari(Tokyo Women's Medical University Hospital)
International Urology and Nephrology
May 7, 2026
Cited by 0


Related Papers